Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2009
03/18/2009EP2035430A1 6h-benzofuro[3,2-c][1]benzopyran and [2]benzopyrano [4,3-b][1]benzopyran derivatives and wood extracts of these compounds as aryl hydrocarbon receptor (ahr) antagonists for the prevention of uv-b induced skin damage
03/18/2009EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
03/18/2009EP2035369A1 Therapeutic compounds
03/18/2009EP2035006A1 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
03/18/2009EP2035004A1 Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
03/18/2009EP2034985A1 Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins
03/18/2009EP1539927B1 Probiotic bacterium: lactobacillus fermentum
03/18/2009EP1495763B1 Therapeutic cream for dermatitis
03/18/2009EP1377273B1 Method for producing an isoflavone concentrate
03/18/2009EP1292316B1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
03/18/2009CN101389612A 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
03/18/2009CN101389610A Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors
03/18/2009CN101389330A Methods for treating cutaneous lupus using aminoisoindoline compounds
03/18/2009CN101389327A Singlet oxygen scavenger, anti-skin-aging agent, anti-wrinkle agent, anti-sagging agent, agent for improving moisture content in the skin, skin-whitening agent, melanin formation inhibitor, nitrogen m
03/18/2009CN101385855A Fine purification method of polyvalent anti-snake venom freeze-dry blood serum
03/18/2009CN101385822A Medicine for mainly treating crural ulcer and preparation method thereof
03/18/2009CN101385811A Medicament for treating psoriasis
03/18/2009CN101385809A Niuxian tea of pure traditional Chinese medicine preparation
03/18/2009CN101385804A New use of traditional Chinese medicine formulation
03/18/2009CN101385800A Skin-protection scream for foot
03/18/2009CN101385799A Chinese herbal medicine for treating empyrosis
03/18/2009CN101385791A Leukoderma treating medicine
03/18/2009CN101385787A New use of white peony root total glycosides in preparing medicine for treating chronic eczema
03/18/2009CN101385781A Traditional Chinese medicine for treating burn and scald
03/18/2009CN101385775A Medicine for treating tinea pedis and preparation method thereof
03/18/2009CN101385745A Agent which is anti-adhesive in relation to the pathogenic flora of the skin
03/18/2009CN101385688A Oilwater emulsion composition containing ascorbic acid-2-phosphate ester magnesium salt
03/18/2009CN101385600A Chinese herbal medicine health-care silk quilt
03/18/2009CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides
03/18/2009CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents
03/18/2009CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors
03/18/2009CN100469764C Vitamin D derivatives
03/18/2009CN100469391C Use of human lysozyme in preparation of medicine for hemorrhoid
03/18/2009CN100469390C Use of bromelain in preparing medicament for increasing individual IL-8 content
03/18/2009CN100469373C Medicine for treating piles and its preparing process
03/18/2009CN100469363C Therapeutic combinations of fatty acids
03/18/2009CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/18/2009CN100469348C Cosmetic/dermatological compositions
03/17/2009US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis
03/17/2009US7504257 Embryonic stem cells and neural progenitor cells derived therefrom
03/17/2009US7504092 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
03/17/2009CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
03/17/2009CA2328234C Compounds that inhibit the binding of integrins to their receptors
03/17/2009CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity
03/17/2009CA2309159C Skin penetration enhancing components
03/17/2009CA2171434C Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/12/2009WO2009032780A2 Method and system for efficiently storing data files
03/12/2009WO2009031916A1 Vip antagonists in the form of an agent for treating psoriasis
03/12/2009WO2009031709A1 Coumarin compound and use thereof
03/12/2009WO2009031708A1 Coumarin compound and use thereof
03/12/2009WO2009031706A1 Coumarin compound and use thereof
03/12/2009WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN
03/12/2009WO2009031644A1 Antifungal pharmaceutical composition
03/12/2009WO2009031642A1 Pharmaceutical composition
03/12/2009WO2009031333A1 Medium for insects belonging to sarcophagidae and calliphoridae in the ovary development stage and egg laying stage, method of feeding insects belonging to sarcophagidae and calliphoridae and insects for medical use
03/12/2009WO2009031106A2 Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
03/12/2009WO2009031099A2 Cosmetic use of microorganisms
03/12/2009WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists
03/12/2009WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists
03/12/2009WO2009030862A2 Use of travoprost for treating hair loss
03/12/2009WO2009030752A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them
03/12/2009WO2009030750A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/12/2009WO2009030746A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/12/2009WO2009030492A2 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion
03/12/2009WO2009030008A1 Process for preparing a plant extract of passiflora alata and use of said extract in cosmetic and pharmaceutical compositions
03/12/2009WO2009029991A1 Agents with angiogenic and wound healing activity
03/12/2009WO2009010478A8 Use of piperidine derivatives as agonists of chemokine receptor activity
03/12/2009WO2008148892A3 Mc- i r, mc-2 r, and mu opioid receptors modulation
03/12/2009US20090069435 Bridged polycyclic compound based compositions for topical applications for pets
03/12/2009US20090069416 Cosmetic Composition for Skin and Wrinkle Improver
03/12/2009US20090069373 Quinoline Acids
03/12/2009US20090069366 Deuterium-enriched tacrolimus
03/12/2009US20090069362 Novel Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors
03/12/2009US20090069336 Pyrimidothiophene compounds
03/12/2009US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity
03/12/2009US20090069307 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
03/12/2009US20090069305 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor
03/12/2009US20090069279 Invert emulsions containing dhea
03/12/2009US20090069278 Hormonally-timed dermatological preparations
03/12/2009US20090069233 Agonist Peptides of Basic Fibroblast Growth Factor (bFGF) and the Method of Reduction of Wrinkles on Skin, Darkening of Hair and Acceleration of Wound Healing
03/12/2009US20090069213 Compositions for Improving the Health and Appearance of Skin
03/12/2009US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt
03/12/2009US20090068255 Use of matrix metalloproteinase inhibitors in skin care
03/12/2009US20090068251 Methods and compositions for promoting wound healing
03/12/2009US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents
03/12/2009US20090068167 Compositions for promoting wound healing and treating psoriasis
03/12/2009US20090068150 Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same
03/12/2009US20090068149 Use of a Fermented Milk Containing L. Casei for the Manufacture of a Composition for the Prevention or Treatment of a Delayed-Type Hypersensitivity Reaction
03/12/2009US20090068132 Resveratrol Ferulate Compounds, Compositions Containing The Compounds, And Methods Of Using The Same
03/12/2009US20090068129 Aminophenylbenzothiazole compounds
03/12/2009CA2698838A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/12/2009CA2698707A1 Release of antibiotic from injectable, biodegradable polyurethane scaffolds for enhanced bone fracture healing
03/12/2009CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
03/12/2009CA2698306A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
03/12/2009CA2698304A1 Novel derivatives of phenylureas, inhibitors of the soat-1 enzyme, pharmaceutical and cosmetic compositions containing them
03/12/2009CA2697735A1 Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin
03/12/2009CA2697537A1 Azithromycin for treatment of skin disorders
03/12/2009CA2696566A1 Process for preparing a plant extract of passiflora alata and use of said extract in cosmetic and pharmaceutical compositions
03/12/2009CA2696129A1 Use of travoprost for treating hair loss
03/11/2009EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation